AG
RMD icon

Advisor Group’s ResMed RMD Stock Holding History

Advisor Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3.11M Buy
20,064
+1,470
+8% +$212K 0.02% 604
2019
Q3 		$2.51M Sell
18,594
-125
-0.7% -$16.4K 0.02% 661
2019
Q2 		$2.29M Buy
18,719
+1,084
+6% +$120K 0.02% 704
2019
Q1 		$1.83M Buy
17,635
+11,779
+201% +$1.22M 0.02% 756
2018
Q4 		$668K Sell
5,856
-720
-11% -$77.1K 0.01% 1209
2018
Q3 		$759K Buy
6,576
+2,957
+82% +$324K 0.01% 1171
2018
Q2 		$376K Sell
3,619
-718
-17% -$72.6K 0.01% 1524
2018
Q1 		$428K Sell
4,337
-556
-11% -$52.5K 0.01% 1428
2017
Q4 		$415K Buy
4,893
+1,729
+55% +$143K 0.01% 1447
2017
Q3 		$244K Buy
3,164
+667
+27% +$51K ﹤0.01% 1702
2017
Q2 		$195K Sell
2,497
-1,801
-42% -$129K ﹤0.01% 1815
2017
Q1 		$310K Buy
4,298
+2,945
+218% +$204K 0.01% 1368
2016
Q4 		$84K Buy
1,353
+159
+13% +$9.74K ﹤0.01% 2200
2016
Q3 		$77K Buy
1,194
+492
+70% +$32.7K ﹤0.01% 2197
2016
Q2 		$43K Buy
+702
New +$41.4K ﹤0.01% 2539

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advisor Group's RMD Position: Q4 2019 in Review

Advisor Group increased its ResMed (RMD) stake by 7.9% in Q4 2019, buying an estimated $212K and bringing the position to 20,064 shares worth $3.11M. The position accounts for 0.02% of the portfolio, ranked #604.

Advisor Group first reported a position in RMD in Q2 2016 and has held it in 15 quarters since. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • Advisor Group held 20,064 shares of ResMed worth $3.11M as of Q4 2019.
  • Advisor Group bought 1,470 ResMed shares in Q4 2019, an estimated $212K.
  • ResMed made up 0.02% of Advisor Group's portfolio in Q4 2019, its #604 holding.
  • Advisor Group first reported a position in ResMed in Q2 2016 and has held it in 15 quarters since.
  • 559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.